FDA reviews ALS drug after lobbying by patients, politicians
[ad_1] When a patient is battling a terminal illness and wants an experimental drug, how much evidence does a regulator need to show it works
[ad_1] When a patient is battling a terminal illness and wants an experimental drug, how much evidence does a regulator need to show it works
[ad_1] SACRAMENTO, Calif. — When Gov. Gavin Newsom took office in 2019, he promised to lower prescription drug costs for all Californians. But now, as
[ad_1] Johnson & Johnson’s Janssen Pharmaceuticals and three other drug companies have agreed to move forward on a $26 billion global opioid settlement, the second
[ad_1] The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug.
[ad_1] Today, the Office of Generic Drugs (OGD) at the Food and Drug Administration (FDA) released its 2021 Annual Report. As noted in the report,
[ad_1] For eight years, Beth Joyner Waldron has counted on Eliquis to treat clots in her lungs and legs. In November 2021, she received a
[ad_1] Yves here. As much as the post below pursues a worthy goal, which is to push back against Big Pharma’s grotesque pricing abuses in
[ad_1] In 2021, the FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new drugs that are either New Molecular Entity (NME) under New
[ad_1] According to the final rule issued last week, the Centers for Medicare and Medicaid Services formally abolished a Trump-era policy that would prevent Medicare
[ad_1] As nervous American hospitals prepare to respond to a new wave of COVID-19 cases caused by the rapidly spreading omicron mutation, doctors warn of
[ad_1] Every once in a while, the system will work. We have embedded a ruling by Judge Colleen McMahon for the Southern District of New
[ad_1] The federal government should provide incentives to encourage drugmakers to produce key drugs and active pharmaceutical ingredients, the alliance of supplier organizations urged in
[ad_1] When a patient is battling a terminal illness and wants an experimental drug, how much evidence does a regulator need to show it works
[ad_1] SACRAMENTO, Calif. — When Gov. Gavin Newsom took office in 2019, he promised to lower prescription drug costs for all Californians. But now, as
[ad_1] Johnson & Johnson’s Janssen Pharmaceuticals and three other drug companies have agreed to move forward on a $26 billion global opioid settlement, the second
[ad_1] The drug industry, patient advocates, and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug.
[ad_1] Today, the Office of Generic Drugs (OGD) at the Food and Drug Administration (FDA) released its 2021 Annual Report. As noted in the report,
[ad_1] For eight years, Beth Joyner Waldron has counted on Eliquis to treat clots in her lungs and legs. In November 2021, she received a
[ad_1] Yves here. As much as the post below pursues a worthy goal, which is to push back against Big Pharma’s grotesque pricing abuses in
[ad_1] In 2021, the FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new drugs that are either New Molecular Entity (NME) under New
[ad_1] According to the final rule issued last week, the Centers for Medicare and Medicaid Services formally abolished a Trump-era policy that would prevent Medicare
[ad_1] As nervous American hospitals prepare to respond to a new wave of COVID-19 cases caused by the rapidly spreading omicron mutation, doctors warn of
[ad_1] Every once in a while, the system will work. We have embedded a ruling by Judge Colleen McMahon for the Southern District of New
[ad_1] The federal government should provide incentives to encourage drugmakers to produce key drugs and active pharmaceutical ingredients, the alliance of supplier organizations urged in